122 related articles for article (PubMed ID: 22025554)
1. Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTL.
Durgeau A; El Hage F; Vergnon I; Validire P; de Montpréville V; Besse B; Soria JC; van Hall T; Mami-Chouaib F
J Immunol; 2011 Dec; 187(11):5532-9. PubMed ID: 22025554
[TBL] [Abstract][Full Text] [Related]
2. TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes.
El Hage F; Durgeau A; Mami-Chouaib F
Ann N Y Acad Sci; 2013 Apr; 1283():75-80. PubMed ID: 23302073
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing.
Leclerc M; Mezquita L; Guillebot De Nerville G; Tihy I; Malenica I; Chouaib S; Mami-Chouaib F
Front Immunol; 2019; 10():1505. PubMed ID: 31333652
[TBL] [Abstract][Full Text] [Related]
4. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
[TBL] [Abstract][Full Text] [Related]
5. The varicellovirus-encoded TAP inhibitor UL49.5 regulates the presentation of CTL epitopes by Qa-1b1.
van Hall T; Laban S; Koppers-Lalic D; Koch J; Precup C; Asmawidjaja P; Offringa R; Wiertz EJ
J Immunol; 2007 Jan; 178(2):657-62. PubMed ID: 17202325
[TBL] [Abstract][Full Text] [Related]
6. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo.
Medina F; Ramos M; Iborra S; de León P; Rodríguez-Castro M; Del Val M
J Immunol; 2009 Oct; 183(7):4639-47. PubMed ID: 19752221
[TBL] [Abstract][Full Text] [Related]
7. A specific cytotoxic T-lymphocyte epitope presentation system for antitumor immunity.
Wu Y; Liu C; Sun M; Shen H; Guo D; Gao B
Int J Cancer; 2010 May; 126(10):2373-86. PubMed ID: 19810094
[TBL] [Abstract][Full Text] [Related]
8. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
Doorduijn EM; Sluijter M; Querido BJ; Oliveira CC; Achour A; Ossendorp F; van der Burg SH; van Hall T
J Clin Invest; 2016 Feb; 126(2):784-94. PubMed ID: 26784543
[TBL] [Abstract][Full Text] [Related]
9. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
[TBL] [Abstract][Full Text] [Related]
10. Spotlight on TAP and its vital role in antigen presentation and cross-presentation.
Mantel I; Sadiq BA; Blander JM
Mol Immunol; 2022 Feb; 142():105-119. PubMed ID: 34973498
[TBL] [Abstract][Full Text] [Related]
11. Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.
Sherritt M; Cooper L; Moss DJ; Kienzle N; Altman J; Khanna R
Int Immunol; 2001 Mar; 13(3):265-71. PubMed ID: 11222495
[TBL] [Abstract][Full Text] [Related]
12. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.
Maeurer MJ; Gollin SM; Martin D; Swaney W; Bryant J; Castelli C; Robbins P; Parmiani G; Storkus WJ; Lotze MT
J Clin Invest; 1996 Oct; 98(7):1633-41. PubMed ID: 8833913
[TBL] [Abstract][Full Text] [Related]
13. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
[TBL] [Abstract][Full Text] [Related]
14. A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens.
Seidel UJ; Oliveira CC; Lampen MH; Hall Tv
Cancer Immunol Immunother; 2012 Jan; 61(1):119-25. PubMed ID: 22116347
[TBL] [Abstract][Full Text] [Related]
15. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
[TBL] [Abstract][Full Text] [Related]
17. Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours.
Durgeau A; Virk Y; Gros G; Voilin E; Corgnac S; Djenidi F; Salmon J; Adam J; de Montpréville V; Validire P; Ferrone S; Chouaib S; Eggermont A; Soria JC; Lemonnier F; Tartour E; Chaput N; Besse B; Mami-Chouaib F
Nat Commun; 2018 Nov; 9(1):5097. PubMed ID: 30504837
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.
Salazar-Onfray F; Charo J; Petersson M; Freland S; Noffz G; Qin Z; Blankenstein T; Ljunggren HG; Kiessling R
J Immunol; 1997 Oct; 159(7):3195-202. PubMed ID: 9317117
[TBL] [Abstract][Full Text] [Related]
19. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
20. TAP-ing into TIEPPs for cancer immunotherapy.
Kiessling R
J Clin Invest; 2016 Feb; 126(2):480-2. PubMed ID: 26784539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
